MétaCan
Menu
← Back to cohort
Record W2338709534 · doi:10.1093/neuonc/nov215.21

GENO-21BRCA1 PROTEIN EXPRESSION PREDICTS SURVIVAL IN GLIOBLASTOMA PATIENTS FROM A NRG ONCOLOGY/RTOG COHORT

2015· article· en· W2338709534 on OpenAlexaff
Maria Vassilakopoulou, Minhee Won, Walter J. Curran, Luís Souhami, Michael D. Prados, Corey J. Langer, David L. Rimm, Jason A. Hanna, Veronique Neumeister, William D. Smart, Aidnag Diaz, James N. Atkins, Lydia Komarnicky, Christopher J. Schultz, Steven Howard, Adam P. Dicker, Jonathan Knisely

Bibliographic record

VenueNeuro-Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsMcGill University
Fundersnot available
KeywordsTemozolomideOncologyMedicineInternal medicineHazard ratioProportional hazards modelPTENTissue microarraySurvival analysisCohortBiomarkerGlioblastomaRadiation therapyImmunohistochemistryCancer researchBiologyConfidence interval

Abstract

fetched live from OpenAlex

BACKGROUND: Glioblastoma multiforme is the most common malignant brain tumor, associated with mean survival <1 year in the pre-temozolomide era. Histologic parameters have had limited value in predicting survival among patients with glioblastoma. Despite advances in recent molecular and genetic profiling studies identifying several prognostic and predictive biomarkers, none has translated into routine clinical use. Our aim was to investigate the expression and prognostic significance of a panel of diverse cellular molecular markers of tumor formation and growth in an annotated glioblastoma tissue microarray. METHODS: A tissue array composed of archived glioblastoma tumors from 66 patients treated with surgery, radiation, and non-temozolomide chemotherapy, was provided by the RTOG. RAD51, BRCA-1, PTEN, and miRNA-210 expression levels were assessed using quantitative in-situ hybridization and automated quantitative protein analysis (AQUA). The objectives of this analysis were to determine the association of each biomarker with overall survival (OS), using the Cox proportional hazard model. Event-time distributions were estimated using the Kaplan-Meier method and compared by the log-rank test. RESULTS: Among the four biomarkers assessed, only BRCA1 expression had a statistically significant correlation with survival. From univariate analysis, patients with low BRCA1 protein expression showed a favorable outcome for OS (p = 0.04; hazard ratio = 0.56) in comparison with high expressors, with median survival times of 18.9 vs. 4.8 months. CONCLUSIONS: BRCA1 protein expression was an important prognostic determinant in our cohort of glioblastoma patients treated with surgery followed by chemo-radio-therapy. This result may imply that low BRCA1 in the tumor, and the consequent low level of DNA repair, causes vulnerability of the cancer cells to treatment. Prospective validation of these results is necessary. This project was supported by grants U10CA21661, U10CA180868, U10CA180822 and U10CA37422 (CCOP) from the National Cancer Institute (NCI) and Genentech.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.291
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-Oncology→Same topicGlioma Diagnosis and Treatment→French-language works237,207→